My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novartis AG Common Stock (NY:NVS)

137.87 -0.85 (-0.61%)

Official Closing Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

53 54 Next >

Chinook Therapeutics Launches Almost 60% On Novartis' $3.5 Billion Takeover ↗

June 12, 2023

Novartis will pay $3.5 billion to buy the kidney disease-focused biotech company.

Via Investor's Business Daily

XPeng's New EV Is a Hit, but This Biotech Stock Is Leaving It in the Dust ↗

June 12, 2023

Find out more about two big winners Monday morning.

Via The Motley Fool

Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories ↗

June 12, 2023

Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger

Via Benzinga

Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today? ↗

June 12, 2023

Chinook Therapeutics (KDNY) stock is rocketing higher on Monday after the company announced it's being acquired by Novartis AG (NVS).

Via InvestorPlace

Hidradenitis Suppurativa Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | InflaRx, Novartis, ChemoCentryx, AnaptysBio, AbbVie, UCB Biopharma

June 12, 2023

Via AB Newswire

Is Novartis a Good Stock to Buy Right Now? ↗

June 07, 2023

The multinational pharma giant excels as an income play.

Via The Motley Fool

Looking At Novartis's Recent Unusual Options Activity ↗

June 01, 2023

Via Benzinga

Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis ↗

May 22, 2023

Via Benzinga

Exploring Novel Approaches to Diabetic Retinopathy Pipeline and Clinical Trials (2023) | Companies – Kodiak Sciences, Novartis, Regenxbio Inc., OcuTerra Therapeutics, Ocular , Bayer, and Others

June 12, 2023

Via AB Newswire

Breakthrough Therapies and Potential Targets for Complement 3 Glomerulopathy Pipeline Analysis (2023) | Companies – ChemoCentryx, Novartis Pharma, Omeros Corporation, Apellis Pharma, and others

June 12, 2023

Via AB Newswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 12, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

Regeneron Pharma Dives As Competition Undercuts Its Biggest Moneymaker ↗

May 04, 2023

Eylea sales fell and missed expectations in the U.S.

Via Investor's Business Daily

Why Are Chinook Therapeutics Shares Trading Higher Today ↗

June 12, 2023

Novartis AG (NYSE: NVS) has agreed to acquire Chinook Therapeutics Inc (NASDAQ: KDNY) for $40 per share in cash,

Via Benzinga

Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low ↗

June 12, 2023

Via Benzinga

Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories ↗

June 08, 2023

Wall Street Journal

Via Benzinga

Novartis' Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations ↗

June 08, 2023

Novartis AG's (NYSE: NVS) generics unit Sandoz tells investors it can add $3 billion in annual sales over the next five years from launching new products after it spins out of its

Via Benzinga

Veterinary Healthcare Product Market to See Huge Growth : Pfizer, Merck, Johnson & Johnson

June 06, 2023

Stay up-to-date with Veterinary Healthcare Product Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application

May 30, 2023

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Admin

Via MarketBeat

Topics Death

Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex

May 26, 2023

Smokeless Tobacco TreatmentÂ Comprehensive Study by Type (Keratosis Treatment, Addiction Treatment, Disease Treatment), Application (Hospitals & Clinics, Academic & Research Organizations, Pharmacies),...

Via SBWire

The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

May 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

Via FinancialNewsMedia

Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis ↗

May 22, 2023

Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ: AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program...

Via Benzinga

Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis ↗

May 22, 2023

Immix Biopharma Inc's (NASDAQ: IMMX) subsidiary Nexcella Inc announced updated AL Amyloidosis clinical data from its ongoing Phase 1b/2a NEXICART-1 study of its BCMA-targeted chimeric antigen receptor...

Via Benzinga

Why Is AVROBIO (AVRO) Stock Up 83% Today? ↗

May 22, 2023

AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).

Via InvestorPlace

Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market

May 18, 2023

Big pharma stocks Novartis, Eli Lilly, Merck, and Novo Nordisk are outperforming the market, driven by successful drugs and strong earnings growth.

Via MarketBeat

Topics Economy

Oral Cancer Treatment Market Projected to Show Strong Growth : Bristol-Myers Squibb, Qilu Pharmaceutical, Novartis

May 15, 2023

Get Oral Cancer Treatment Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.

Via SBWire

AI for Pharma and Biotech Market Giants Spending Is Going to Boom : PFIZER, Abbott, SANOFI, Atomwise

May 09, 2023

Stay up-to-date with AI for Pharma and Biotech Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Topics Artificial Intelligence

Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance ↗

May 09, 2023

Via Benzinga

What's Going On With Immix Biopharma Stock Today ↗

May 03, 2023

Immix Biopharma Inc (NASDAQ: IMMX) announced early interim data from IMMINENT-01 Phase 1b/2a trial combining tissue-specific therapeutic IMX-110 with BeiGene Ltd (NYSE: BGNE) / Novartis AG'

Via Benzinga

Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents ↗

May 03, 2023

Amgen Inc (NASDAQ: AMGN) has reportedly sued Novartis AG's (NYSE: NVS) Generic arm Sandoz on proposed versions of its bone-strengthening drugs Prolia and Xgeva containing denosumab, infringing several...

Via Benzinga

Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine ↗

May 02, 2023

Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.